These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22369201)

  • 1. Liverome: a curated database of liver cancer-related gene signatures with self-contained context information.
    Lee L; Wang K; Li G; Xie Z; Wang Y; Xu J; Sun S; Pocalyko D; Bhak J; Kim C; Lee KH; Jang YJ; Yeom YI; Yoo HS; Hwang S
    BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S3. PubMed ID: 22369201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.
    Staib F; Krupp M; Maass T; Itzel T; Weinmann A; Lee JS; Schmidt B; Müller M; Thorgeirsson SS; Galle PR; Teufel A
    Liver Int; 2014 Apr; 34(4):621-31. PubMed ID: 24016071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients.
    Wang L; Zhou N; Qu J; Jiang M; Zhang X
    Mol Med; 2020 Dec; 26(1):125. PubMed ID: 33297932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies.
    Yue Z; Zhang E; Xu C; Khurana S; Batra N; Dang SDH; Cimino JJ; Chen JY
    Nucleic Acids Res; 2021 Jan; 49(D1):D589-D599. PubMed ID: 33245774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci.
    Su WH; Chao CC; Yeh SH; Chen DS; Chen PJ; Jou YS
    Nucleic Acids Res; 2007 Jan; 35(Database issue):D727-31. PubMed ID: 17098932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LiverAtlas: a unique integrated knowledge database for systems-level research of liver and hepatic disease.
    Zhang Y; Yang C; Wang S; Chen T; Li M; Wang X; Li D; Wang K; Ma J; Wu S; Zhang X; Zhu Y; Wu J; He F
    Liver Int; 2013 Sep; 33(8):1239-48. PubMed ID: 23601370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling.
    Ouyang J; Sun Y; Li W; Zhang W; Wang D; Liu X; Lin Y; Lian B; Xie L
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2688-95. PubMed ID: 26940364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.
    Lian Q; Wang S; Zhang G; Wang D; Luo G; Tang J; Chen L; Gu J
    Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):269-275. PubMed ID: 30266410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Analysis of Transcriptomic and Proteomic Data for Deciphering Molecular Heterogeneity and Drug Responsiveness in Model Human Hepatocellular Carcinoma Cell Lines.
    Agioutantis PC; Loutrari H; Kolisis FN
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32517019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.
    Chu YW; Chien CH; Sung MI; Chen CW; Chen YT
    PLoS One; 2020; 15(6):e0234084. PubMed ID: 32497121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.
    Hu B; Yang XB; Sang XT
    Cancer Med; 2020 Oct; 9(20):7646-7662. PubMed ID: 32813933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
    Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
    EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 15. GEM-TREND: a web tool for gene expression data mining toward relevant network discovery.
    Feng C; Araki M; Kunimoto R; Tamon A; Makiguchi H; Niijima S; Tsujimoto G; Okuno Y
    BMC Genomics; 2009 Sep; 10():411. PubMed ID: 19728865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GeneSigDB--a curated database of gene expression signatures.
    Culhane AC; Schwarzl T; Sultana R; Picard KC; Picard SC; Lu TH; Franklin KR; French SJ; Papenhausen G; Correll M; Quackenbush J
    Nucleic Acids Res; 2010 Jan; 38(Database issue):D716-25. PubMed ID: 19934259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCC.
    Becker D; Sfakianakis I; Krupp M; Staib F; Gerhold-Ay A; Victor A; Binder H; Blettner M; Maass T; Thorgeirsson S; Galle PR; Teufel A
    Mol Cancer; 2012 Aug; 11():55. PubMed ID: 22891627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma.
    Ivanovska I; Zhang C; Liu AM; Wong KF; Lee NP; Lewis P; Philippar U; Bansal D; Buser C; Scott M; Mao M; Poon RT; Fan ST; Cleary MA; Luk JM; Dai H
    PLoS One; 2011; 6(9):e24582. PubMed ID: 21949730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.